Inhaled Corticosteroids in U-5 Children With Acute Respiratory Infection in Uganda: A Randomised Trial

PHASE3CompletedINTERVENTIONAL
Enrollment

1,010

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

January 31, 2014

Study Completion Date

January 31, 2014

Conditions
Bacterial PneumoniaViral PneumoniaAcute Asthma
Interventions
DRUG

Inhaled corticosteroid

Inhaled fluticasone 500mcg 12 hourly up to discharge or a maximum of 5 days

OTHER

Placebo

Placebo to be administered 12hourly

Trial Locations (1)

Unknown

Makerere University College of Health Sciences, Kampala

All Listed Sponsors
collaborator

University of Copenhagen

OTHER

lead

Makerere University

OTHER

NCT01868113 - Inhaled Corticosteroids in U-5 Children With Acute Respiratory Infection in Uganda: A Randomised Trial | Biotech Hunter | Biotech Hunter